The NHS Obesity & Weight Management Formulary has been updated to reflect the latest NICE guidance, including new criteria for prescribing Semaglutide to reduce cardiovascular risk in overweight patients with CVD. The formulary is now split into separate oral and injectable medication pages, with clear advice, tick boxes for clinical checks, and links to relevant NHS pathways. These changes ensure clinicians have up-to-date, easy-to-navigate resources for safe and effective obesity management.